Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cellular Biochemistry|December 11, 2024
Effective Targeting of Colorectal Cancer Stem Cells by Inducing Differentiation Mediated by Low-Dose Vitamin C via β-Catenin Retention in the Cell MembraneShanooja Shanavas, Utsav Sen, Rajkumar Banerjee, et al.
Life Sciences|October 5, 2023
Mitigation of chronic glucotoxicity-mediated skeletal muscle atrophy by arachidonic acidAkash Mitra, Shanooja Shanavas, Debajit Chaudhury, et al.
RSC Advances|April 28, 2022
Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468Ashaparna Mondal, Shanooja Shanavas, Utsav Sen, et al.
Journal of Medicinal Chemistry|May 30, 2024
2-Aryl-1H-imidazo[4,5-f][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic AgentsBinoy Kar, Shanooja Shanavas, Arun Karmakar, et al.
Journal of Medicinal Chemistry|December 7, 2025
Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231Rishav Das, Shanooja Shanavas, Utpal Das, et al.
Cell Biology International|December 27, 2022
Significance of Oct-4 transcription factor as a pivotal therapeutic target for CD44+ /24- mammary tumor initiating cells: Aiming at the root of the recurrenceUtsav Sen, Shanooja Shanavas, Apoorva H Nagendra, et al.
ACS Applied Bio Materials|January 13, 2023
Luminescent 11-{Naphthalen-1-yl}dipyrido[3,2-a:2',3'-c]phenazine-Based Ru(II)/Ir(III)/Re(I) Complexes for HCT-116 Colorectal Cancer Stem Cell TherapyUtpal Das, Shanooja Shanavas, Apoorva H Nagendra, et al.
ACS Omega|April 10, 2023
G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2'-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC CellsNilmadhab Roy, Shanooja Shanavas, Binoy Kar, et al.
Journal of Medicinal Chemistry|February 5, 2025
Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer TreatmentUtpal Das, Shanooja Shanavas, Meena Jayaprakash, et al.
Dalton Transactions (Cambridge, England : 2003)|February 25, 2025
The role of ancillary ligands on benzodipyridophenazine-based Ru(II)/Ir(III) complexes in dark and light toxicity against TNBC cellsNivedya T, Rishav Das, Selva Kumar R, et al.
Pageof 2